title: Loss of lineage antigens is a common feature of apoptotic lymphocytes.
abstract: The analysis of apoptosis in cell populations involves the detection of their specific lineage antigen (LAg) expression. This experimental approach relies on their assumed constant expression, but it is unclear whether such expression is actually maintained during cell death. We examined whether the loss of LAgs is a common feature of apoptotic lymphocytes and whether some might completely lose their LAgs. The changes in the expression of CD3, CD5, CD8, CD4, CD28, CD56, and CD19 were monitored in highly purified lymphocyte populations obtained by negative selection in a fluorescence-activated cell sorter. These were cultured for 24 h with or without phytohemagglutinin or staurosporin. For each LAg-positive subset studied, apoptosis was consistently more common among cells showing partial or total loss of LAg expression compared with cells maintaining their initial LAg levels. The kinetics of expression loss was rapid for CD8, CD56, and CD28, and more than 80% of initial expression was lost in the early stages of apoptosis but was slower for CD3, CD5, and CD4. For CD3 and CD5, expression was dependent on the apoptotic stimulus used. It is interesting that loss of antigen expression was independent of cell size. This phenomenon was also found in nonmanipulated, highly pure CD19 B lymphocytes of peripheral blood mononuclear cells from B chronic lymphocytic leukemia patients. Loss of LAg expression appeared to be a common feature of apoptotic lymphocytes under all the conditions assayed. The different kinetic patterns of LAg loss suggest apoptotic cells might actively regulate this process.
authors.affiliation: Associated Unit, Department of Medicine, University of Alcalá, Carretera Madrid, Spain.
authors.forename: D
authors.initials: D
authors.lastname: Diaz
authors.forename: A
authors.initials: A
authors.lastname: Prieto
authors.forename: H
authors.initials: H
authors.lastname: Barcenilla
authors.forename: J
authors.initials: J
authors.lastname: Monserrat
authors.forename: P
authors.initials: P
authors.lastname: Prieto
authors.forename: M A
authors.initials: MA
authors.lastname: Sánchez
authors.forename: E
authors.initials: E
authors.lastname: Reyes
authors.forename: M P
authors.initials: MP
authors.lastname: Hernandez-Fuentes
authors.forename: A
authors.initials: A
authors.lastname: de la Hera
authors.forename: A
authors.initials: A
authors.lastname: Orfao
authors.forename: M
authors.initials: M
authors.lastname: Alvarez-Mon
mesh_terms: D015703:Antigens, CD / Q000276:immunology* / Q000378:metabolism*; D017209:Apoptosis / Q000276:immunology*; D019070:Cell Lineage / Q000276:immunology; D005434:Flow Cytometry; D006801:Humans; D007700:Kinetics; D015448:Leukemia, B-Cell / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology* / Q000378:metabolism*; D010835:Phytohemagglutinins / Q000494:pharmacology; D019311:Staurosporine / Q000494:pharmacology
chemical_list: D015703:Antigens, CD; D010835:Phytohemagglutinins; D019311:Staurosporine